scispace - formally typeset
M

Maísa Corrêa

Researcher at Universidade Federal de Santa Maria

Publications -  32
Citations -  1157

Maísa Corrêa is an academic researcher from Universidade Federal de Santa Maria. The author has contributed to research in topics: Adenine nucleotide & Acetylcholinesterase. The author has an hindex of 21, co-authored 32 publications receiving 1069 citations.

Papers
More filters
Journal ArticleDOI

Resveratrol prevents memory deficits and the increase in acetylcholinesterase activity in streptozotocin-induced diabetic rats.

TL;DR: It is shown that treatment with resveratrol prevents the increase in AChE activity and consequently memory impairment in diabetic rats, demonstrating that this compound can modulate cholinergic neurotransmission and consequently improve cognition.
Journal ArticleDOI

Acetylcholinesterase activation and enhanced lipid peroxidation after long-term exposure to low levels of aluminum on different mouse brain regions.

TL;DR: The effect of aluminum on AChE activity may be due to a direct neurotoxic effect of the metal or perhaps a disarrangement of the plasmatic membrane caused by increased lipid peroxidation.
Journal ArticleDOI

Effect of long-term exposure to aluminum on the acetylcholinesterase activity in the central nervous system and erythrocytes.

TL;DR: Results indicate that Al affects at the same way AChE activity in the central nervous system and erythrocyte, and may be considered a marker of easy access of the central cholinergic status.
Journal ArticleDOI

Effects of resveratrol on nucleotide degrading enzymes in streptozotocin-induced diabetic rats

TL;DR: The present findings demonstrate alterations in nucleotide hydrolysis in platelets of STZ-induced diabetic rats and treatment with RSV was able to modulate adenine nucleotide Hydrolysis, which may be important in the control of the platelet coagulant status in diabetes.
Journal ArticleDOI

Inhibition of two different cholinesterases by tacrine

TL;DR: The present results suggest that this therapeutic agent used for the treatment of Alzheimer's disease can also be considered an inhibitor of snake venom and human serum butyrylcholinesterase.